Publication | Closed Access
Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
698
Citations
16
References
2006
Year
Distinctive Magnetic ResonanceNeurological DisorderNeurological ProgressPathologyHigh Aquaporin 4Peripheral NervesOptic NerveSocial SciencesNeurobiology Of DiseaseNeurologyNeuropathologyNeuroimmunologyNeurological MonitoringCiliary BodyCerebral Blood FlowAqueous HumourNeuromuscular PathologyNeurophysiologyNeuroanatomyCellular NeuroscienceMammalian BrainNeuroscienceGlaucomaCentral Nervous SystemMedicine
Neuromyelitis optica is marked by an IgG autoantibody that binds aquaporin‑4, a protein densely expressed in astrocytic foot processes at the blood‑brain barrier, and brain MRI abnormalities are common despite the belief that the brain is spared. The study aimed to determine whether NMO‑specific brain lesions localize to regions of high aquaporin‑4 expression. An observational, retrospective case series of 120 NMO‑IgG seropositive patients with available brain MRI was conducted to assess imaging abnormalities. Eight patients exhibited recurrent, distinctive MRI lesions in the hypothalamic and periventricular regions that matched areas of high aquaporin‑4 expression, indicating that NMO brain lesions correspond to sites of high AQP4.
<h3>Background</h3> Neuromyelitis optica (NMO)–IgG is a specific autoantibody marker for NMO. It binds selectively to aquaporin 4 (AQP4), which is highly concentrated in astrocytic foot processes at the blood-brain barrier and is not restricted to optic nerve and spinal cord. Although it is conventionally believed that the brain is spared, brain imaging abnormalities are not uncommon in patients with NMO. <h3>Objective</h3> To investigate the location of brain lesions that are distinctive for NMO with respect to the localization of AQP4 in mammalian brain. <h3>Design</h3> Observational, retrospective case series. <h3>Setting</h3> Clinical serologic cohort of patients tested for NMO-IgG for whom brain MRI images were available. <h3>Patients</h3> We identified 120 patients seropositive for NMO-IgG for whom brain magnetic resonance images were available. <h3>Main Outcome Measure</h3> Magnetic resonance imaging abnormalities. <h3>Results</h3> In 8 patients we observed recurring and distinctive magnetic resonance imaging abnormalities in the hypothalamic and periventricular areas that corresponded to brain regions of high AQP4 expression. <h3>Conclusion</h3> The distribution of NMO-characteristic brain lesions corresponds to sites of high AQP4 expression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1